🇺🇸 FDA
Patent

US 6451763

Retinal pigmented epithelium derived neurotrophic factor and methods of use

expired A61KA61K38/00

Quick answer

US patent 6451763 (Retinal pigmented epithelium derived neurotrophic factor and methods of use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00